Stocks
Iovance Biotherapeutics (IOVA) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 400% | 431.1% | 689.4% | 1 443% | 1 544% | 2 704% | |||
| Changes by years, y/y, % | -5 933pp | -1 969pp | +258pp | +754pp | +100pp | -28.6% | |||
Iovance Biotherapeutics. R&D/CAPEX, %
Iovance Biotherapeutics. R&D/CAPEX, changes, pp
Iovance Biotherapeutics (IOVA) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 907.0% | 2 447% | 2 479% | 1 913% | 14 046% | 2 704% | ||
| Changes by years, y/y, % | -697pp | -2 780pp | -188pp | +452pp | +13 139pp | |||
| Changes by quarters, q/q, % | -554pp | +1 540pp | +32pp | -566pp | +12 133pp | |||
